Encompass Health reaffirms FY2025 guidance during investor meetings

Encompass Health Corp

Net operating revenue guidance of $5.88B-$5.98B for FY2025.
Adjusted EBITDA guided at $1.22B-$1.25B; adjusted EPS $5.12-$5.34.
Reiteration provided at meetings on Sept 12, Oct 1, and Oct 6, 2025.
Previous guidance from Aug 4/5, 2025 remains unchanged.

item 7.01

Source: SEC EDGAR

accession 0000785161-25-000070

view filing index on sec.gov

view primary document

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.